The Endocannabinoid System Controls Metabolism Throughout the Body, Not Just Appetite in the Brain
A review of endocannabinoid system research reveals that peripheral CB1 receptors in fat tissue, liver, and muscle regulate metabolism independently of brain effects, opening new treatment possibilities after rimonabant's withdrawal.
Quick Facts
What This Study Found
This review charted the evolution of understanding about the endocannabinoid system (ECS) and metabolism. Early research focused on the brain: CB1 receptors in the hypothalamus and reward circuits drove food intake and energy balance. This led to rimonabant, a brain-penetrant CB1 antagonist that effectively treated obesity and metabolic disorders but was withdrawn in 2009 due to psychiatric side effects (depression, anxiety, suicidal ideation).
However, research has since revealed extensive peripheral ECS involvement in metabolism. CB1 receptors in adipose tissue, liver, skeletal muscle, and pancreas regulate fat storage, insulin sensitivity, lipid metabolism, and glucose homeostasis independently of brain effects. Peripherally restricted CB1 antagonists that cannot cross the blood-brain barrier have shown effectiveness in reducing body weight, adiposity, insulin resistance, and dyslipidemia in obese animal models, without the psychiatric side effects.
New developments include the discovery of endogenous allosteric inhibitors of CB1, the crystal structure of human CB1, and evidence that CB2 receptors also participate in metabolic regulation.
Key Numbers
Rimonabant was removed from the market in 2009. CB1 receptors are present in adipose tissue, liver, skeletal muscle, and pancreas. Peripherally restricted CB1 antagonists reduced body weight and metabolic markers in obese animals without CNS side effects.
How They Did This
Comprehensive narrative review covering the history, current state, and future directions of endocannabinoid system involvement in metabolic regulation.
Why This Research Matters
The withdrawal of rimonabant was a major setback for cannabinoid-based metabolic therapy. This review shows that the science did not stop there: peripheral ECS modulation may achieve the metabolic benefits of rimonabant without the psychiatric risks. Understanding how the endocannabinoid system regulates metabolism also explains aspects of the "munchies" and why chronic cannabis users have paradoxically been associated with lower obesity rates in some studies.
The Bigger Picture
The relationship between cannabis, the endocannabinoid system, and metabolism is more nuanced than "THC gives you the munchies." The ECS is a fundamental regulator of energy balance throughout the body, and its modulation offers therapeutic potential for obesity, diabetes, and metabolic syndrome. The challenge is harnessing these benefits without disrupting brain endocannabinoid signaling.
What This Study Doesn't Tell Us
Narrative review with potential for selective citation. Peripherally restricted CB1 antagonists have only been tested in animals at the time of this review. The complexity of the ECS makes predicting clinical outcomes from preclinical data particularly challenging. The full consequences of chronically blocking peripheral CB1 receptors are unknown.
Questions This Raises
- ?Will peripherally restricted CB1 antagonists prove safe and effective in humans?
- ?How does chronic cannabis use affect peripheral metabolic ECS signaling?
- ?Could understanding the ECS explain the paradox of lower obesity in some cannabis-using populations?
Trust & Context
- Key Stat:
- Peripherally restricted CB1 blockers improved metabolism in animals without psychiatric side effects
- Evidence Grade:
- Strong evidence from a comprehensive review synthesizing decades of preclinical and clinical metabolic research.
- Study Age:
- Published in 2017. Peripheral ECS modulation for metabolic disease remains an active area of drug development.
- Original Title:
- MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
- Published In:
- European journal of endocrinology, 176(6), R309-R324 (2017)
- Authors:
- Simon, Vincent, Cota, Daniela(3)
- Database ID:
- RTHC-01520
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why does cannabis give you the munchies?
THC activates CB1 receptors in the brain's hypothalamus and reward circuits, increasing appetite and the pleasure of eating. But this review shows the endocannabinoid system also controls metabolism in fat tissue, liver, and muscle, meaning cannabis affects energy balance through multiple pathways beyond just making you hungry.
If blocking CB1 receptors causes depression, how can it be used for weight loss?
Rimonabant blocked CB1 receptors throughout the brain, including in mood-regulating circuits. New "peripherally restricted" CB1 blockers are designed to stay out of the brain, only blocking CB1 in fat tissue, liver, and muscle. In animal studies, these achieved metabolic benefits without psychiatric side effects.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01520APA
Simon, Vincent; Cota, Daniela. (2017). MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.. European journal of endocrinology, 176(6), R309-R324. https://doi.org/10.1530/EJE-16-1044
MLA
Simon, Vincent, et al. "MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.." European journal of endocrinology, 2017. https://doi.org/10.1530/EJE-16-1044
RethinkTHC
RethinkTHC Research Database. "MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism..." RTHC-01520. Retrieved from https://rethinkthc.com/research/simon-2017-mechanisms-in-endocrinology-endocannabinoids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.